HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Djordje Atanackovic Selected Research

elotuzumab

1/2017Elotuzumab as a novel anti-myeloma immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Djordje Atanackovic Research Topics

Disease

51Neoplasms (Cancer)
02/2022 - 09/2002
35Multiple Myeloma
12/2021 - 06/2006
15Testicular Neoplasms (Testicular Cancer)
12/2020 - 03/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 03/2004
5Graft vs Host Disease (Graft-Versus-Host Disease)
02/2013 - 06/2006
4Stomach Neoplasms (Stomach Cancer)
10/2015 - 11/2010
3B-Cell Lymphoma (Lymphoma, B Cell)
02/2022 - 01/2017
3COVID-19
01/2022 - 07/2021
3Lung Neoplasms (Lung Cancer)
01/2016 - 03/2004
3Disease Progression
12/2015 - 02/2009
3Adenocarcinoma
10/2015 - 09/2010
3Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 07/2010
3Ascites
12/2013 - 04/2004
3Human Influenza (Influenza)
06/2013 - 07/2003
3Hyperthermia
03/2006 - 12/2002
2Lymphoma (Lymphomas)
01/2022 - 01/2017
2Ewing Sarcoma (Sarcoma, Ewing)
12/2021 - 12/2020
2Melanoma (Melanoma, Malignant)
05/2019 - 09/2014
2Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 02/2014
2Residual Neoplasm
10/2015 - 01/2015
2Squamous Cell Carcinoma of Head and Neck
09/2014 - 09/2006
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014 - 12/2010
2Neoplasm Metastasis (Metastasis)
06/2013 - 12/2009
1Cytopenia
11/2021
1Supraventricular Tachycardia
01/2018
1Diarrhea
01/2018
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2016
1Neutropenia
10/2015
1Chills
10/2015

Drug/Important Bio-Agent (IBA)

24AntigensIBA
01/2022 - 09/2002
12Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2002
7AntibodiesIBA
12/2021 - 07/2003
7Monoclonal AntibodiesIBA
12/2020 - 06/2003
6Chimeric Antigen ReceptorsIBA
02/2022 - 03/2016
5CytokinesIBA
02/2014 - 09/2005
5Neoplasm Antigens (Tumor Antigens)IBA
01/2014 - 07/2010
5EpitopesIBA
06/2013 - 09/2002
4Biomarkers (Surrogate Marker)IBA
10/2018 - 10/2010
4AutoantibodiesIBA
11/2014 - 01/2010
4Peptides (Polypeptides)IBA
07/2010 - 09/2002
3Epithelial Cell Adhesion MoleculeIBA
01/2018 - 12/2013
3Interleukin-16 (Interleukin 16)IBA
07/2017 - 10/2010
3Proteasome InhibitorsIBA
01/2017 - 01/2011
3Biological ProductsIBA
12/2015 - 05/2010
3Tyrosine Kinase InhibitorsIBA
01/2014 - 12/2012
3Indicators and Reagents (Reagents)IBA
12/2012 - 04/2004
3Bortezomib (Velcade)FDA Link
01/2011 - 06/2006
2VaccinesIBA
01/2022 - 03/2004
2Antiviral Agents (Antivirals)IBA
12/2021 - 07/2021
2Immunoglobulin G (IgG)IBA
12/2021 - 01/2012
2daratumumabIBA
12/2021 - 01/2016
2isatuximabIBA
12/2021 - 01/2020
2Cancer VaccinesIBA
12/2020 - 03/2004
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2020 - 06/2013
2Hormones (Hormone)IBA
01/2016 - 03/2006
2catumaxomabIBA
10/2015 - 12/2013
2Bevacizumab (Avastin)FDA Link
09/2015 - 12/2009
2Antigen-Antibody Complex (Immune Complex)IBA
11/2014 - 09/2002
2ErbB Receptors (EGF Receptor)IBA
06/2013 - 09/2010
2Lenalidomide (CC 5013)FDA Link
02/2013 - 05/2010
2Pharmaceutical PreparationsIBA
11/2010 - 12/2009
2ChemokinesIBA
10/2010 - 01/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009 - 01/2008
2Chemokine ReceptorsIBA
09/2005 - 04/2004
1mRNA VaccinesIBA
01/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2020
1Surface Antigens (Surface Antigen)IBA
12/2020
1ProteomeIBA
12/2020
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
04/2020
1B-Cell Maturation AntigenIBA
04/2020
1SurvivinIBA
05/2019
1Messenger RNA (mRNA)IBA
05/2019
1Glycoproteins (Glycoprotein)IBA
05/2019
1SolventsIBA
11/2018
1Aromatic HydrocarbonsIBA
11/2018
1IpilimumabIBA
10/2018
1SolitomabIBA
01/2018
1Histones (Histone)IBA
01/2018
1EnzymesIBA
01/2018
1Lipase (Acid Lipase)FDA Link
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Phosphotransferases (Kinase)IBA
07/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1Immunomodulating AgentsIBA
01/2017
1elotuzumabIBA
01/2017
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2016
1Vinorelbine (Navelbine)FDA LinkGeneric
10/2015

Therapy/Procedure

22Therapeutics
02/2022 - 12/2009
21Immunotherapy
12/2021 - 09/2006
14Drug Therapy (Chemotherapy)
03/2016 - 12/2002
13Stem Cell Transplantation
07/2021 - 06/2006
2Transplantation
02/2014 - 03/2013
1Kidney Transplantation
07/2021
1Immunomodulation
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017
1Hormonal Contraception
01/2016
1Combined Modality Therapy
10/2015
1Neoadjuvant Therapy
10/2015
1Adjuvant Chemotherapy
10/2015